Paediatric population with Diabetes 1 that requires Insuline Injection Dispositives present complication in their skin for many reasons.
We are now trying to development a clinical experience with skin barriers in those patientes.
Thanks for your attention and collaboration.
Regards,
Martha Uruena-Cartagena